Exciting new series on “Voice, Body and Movement for Lawyers – How to connect with the jury and find Justice Through Dramatic Technique!”
Click here to find out moreKirkland & Ellis attorneys will discuss various issues that shaped litigation strategies in the pharmaceutical patent space in 2023, including continued development of enablement jurisprudence under Amgen, updates on “skinny label” induced infringement claims, and government publications ranging from the use of artificial intelligence in drug development to government enforcement action related to pharmaceutical patents.
Attendees will develop an appreciation for relevant 2023 legal/regulatory updates in the pharmaceutical patent space, and the presenters will provide strategic insight as to what to look ahead to in 2024.
